Dr. Saladin Sawan Consultant Gynecological Oncology and Robotic Surgeon
Years of Experience : 35
Nationality : UK
Languages Known : English , Arabic
Biography
Dr. Saladin Sawan is one of the few surgeons in the UAE licensed by DOH to offer surgical treatment for patients with gynecological cancers. He is dual accredited from the United Kingdom (CCT: Certificate of Completion of Training) in Gynecological Oncology and Obstetrics and Gynecology. Dr. Saladin is an accomplished Surgeon in treating Gynecological Cancers; he has been the Clinical Lead Surgeon for Gynaecology Oncology at the James Cook Gynaecological Oncology Centre and the Chair for the multidisciplinary team (MDT), guiding the team to improve performance efficiency and to comply with national standards. Saladin Has also led the Colposcopy and Vulval Disease services advising the team on managing premalignant and malignant conditions; he had a dedicated tertiary clinic seeing patients with complex disease. Dr. Saladin has been awarded an MRES in cancer immunology, and a Ph.D. is studying mechanistic ovarian cancer metastasis from the internationally renowned CRUK Manchester. As a Consultant Surgeon in gynecological oncology, Dr. Saladin has been trained in outstanding cancer centers, The Christie, St Mary’s in Manchester, and the Peritoneal Malignancy Institute in Basingstoke. Saladin is competent in pelvic and abdominal surgery as applied for gynecological malignancies. He is passionate about delivering the best evidence-based care for women with gynecological cancers. Therefore, he is well placed to explore novel therapies such as intra-peritoneal therapeutics, including HIPEC and targeted therapies. Dr. Saladin has a special interest and expertise in fertility-sparing surgery for women suffering from gynecological cancers. Dr. Saladin has a keen interest in teaching surgical skills and clinical knowledge to trainees in Obstetrics and Gynecology and subspecialty trainees in Gynaecological Oncology and co-supervise Ph.D. and MSc students. His areas of expertise include,
- Robotic total (and radical) hysterectomy, robotic pelvic and lower para-aortic lymphadenectomy
- Trachelectomy
- Cytoreductive surgery gynecological cancers including bowel resection, peritoneal stripping, and splenectomy
- Pelvic exenteration surgery (anterior, posterior, and total)
- Laparoscopic total and radical hysterectomy, laparoscopic pelvic lymphadenectomy
- Vulvectomy with reconstructive surgery, groin node sentinel sampling, and full lymphadenectomy
- Ovarian (fallopian) tubal and primary peritoneal cancer
- Endometrial and uterine malignancies
- Endometrial hyperplasia
- Cervical and vaginal cancers and pre-cancer conditions
- Cervical cancer screening
- Vulval cancer and pre-cancer conditions of the vulva in addition to complex vulval disease including chronic pain and itchiness
- Follow up of patients who have had treatment for gynecology cancers
Awards & Achievements
- £2M award to a collaboration of South Tees Hospitals, Nottingham University, and combat to investigate the efficacy and safety of delivering intraperitoneal chemotherapy, including establishing a HIPEC center in James Cook Hospital. Biomedical Catalyst (BMC) from the MRC and Innovate UK ESGO Travelling Fellowship to visit the Netherlands Kanker Institute in Amsterdam to investigate the role of HIPEC in ovarian cancer. BSGE Trainees Travel Fellowship to support robotic surgery training Florence and William Blair Bell Research Fellowship - RCOG Integrin-driven invasion in ovarian cancer
- World Wide Cancer Research (formerly AICR) - £178K research funding
- Trafficking integrins in epithelial ovarian cancer
- Manchester Cancer Research Centre (MCRC), Co-Supervisor, Ph.D. studentship, £100K research funding
- The Institute of Cancer Sciences (ICS) Travel Bursary, The University of Manchester, presents my 5T4 project results at the ESGO conference
- The Joseph Starkey Ph.D. Fellowship, Wigan, and District Cancer Research Committee
- Eden Travelling Fellowship Award in Obstetrics and Gynecology, RCOG to visit the ‘Ellis Fischel Cancer Center’ in Columbia, Missouri, USA
- Member of Royal College of Obstetricians and Gynecologists (RCOG)
- Member of Scientific Committee and the Quality Assurance Group in the RCOG
- Member of British and Irish Association of Robotic Gynecological Surgeons (BIARGS)
- Member of British Gynecological Cancer Society (BGCS)
- Member of European Society of Gynecological Oncology (ESGO)
- Member of European Society of Surgical Oncology (ESSO)
- Member of British Society of Colposcopy and Cervical Pathology (BSCCP)
Research & Publications
- HIPEC and NIPEC: Awarded the prestigious Biomedical Catalyst (BMC).
- Exploring Deep and Machine Learning in ovarian cancer stratification’: December 2018 to date, Teesside University.
- Integrin-mediated invasion in ovarian cancer’: 2015 - 2017, collaborator. Wellcome Trust Centre for Cell-Matrix Research, The University of Manchester.
- 5T4 role in epithelial ovarian cancer metastasis’: 2010 - 2015, Immunology Group, Paterson Institute for Cancer Research (PICR), The University of Manchester.
- Systemic and local immune responses in endometrial cancer’: 2006 – 2009, Immunology Group, Paterson Institute for Cancer Research (PICR), The University of Manchester.
- Leg lymphoedema prevention following vulval cancer treatment’: 2005 – 2006, Northern Gynaecological Oncology Centre (NGOC), Gateshead.
- MutaTah Hira, M.A. Razzaque, Claudio Angione, James Scrivens, Saladin Sawan, and Mosharraf Sarkar. “Integrated multi-omics analysis of ovarian cancer using variational autoencoders,” Scientific Reports, 6265 (2021).
- Lisa A. Sheehan, Akash M. Mehta, Saladin Sawan, Sanjeev P. Dayal, Faheez Mohamed, Brendan J. Moran, and Tom D. Cecil. “Preserving fertility in pseudomyxoma peritonei, a novel approach,” Pleura and Peritoneum, Feb 2017.
- S. Sawan, R.J. Edmondson, Should we worry about obesity in our ovarian cancer patients, too? BJOG: An International Journal of Obstetrics and Gynaecology 123 (2016).
- Stern PL, Brazzatti J, Sawan S, McGinn OJ. Understanding and exploiting 5T4 oncofoetal glycoprotein expression. Seminars in Cancer Biology, 2014.
- Owen J. McGinn, Georgi Marinov, Saladin Sawan, and Peter L. Stern; CXCL12 receptor preference, signal transduction, biological response, and the expression of 5T4 oncofoetal glycoprotein. Journal of Cell Science, 2012.
- Sawan, S, Burt, D, Stern, P, Holland, C and Elkord, E, 'Circulating regulatory T cells in endometrial cancer: a role for age and menopausal status,' Immunological Investigations - A Journal of Molecular and Cellular Immunology, 2011.
- Sawan S; Mugnai R; Lopes A; Hughes A; Edmondson RJ. Lower limb lymphoedema and vulval cancer: feasibility of prophylactic compression garments and validation of leg volume measurement. International Journal of Gynecological Cancer, 2009.